Global Minimal Residual Disease (MRD) Testing Supply, Demand and Key Producers, 2023-2029

Global Minimal Residual Disease (MRD) Testing Supply, Demand and Key Producers, 2023-2029

The global Minimal Residual Disease (MRD) Testing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Minimal Residual Disease (MRD) Testing demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Minimal Residual Disease (MRD) Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Minimal Residual Disease (MRD) Testing that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Minimal Residual Disease (MRD) Testing total market, 2018-2029, (USD Million)

Global Minimal Residual Disease (MRD) Testing total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Minimal Residual Disease (MRD) Testing total market, key domestic companies and share, (USD Million)

Global Minimal Residual Disease (MRD) Testing revenue by player and market share 2018-2023, (USD Million)

Global Minimal Residual Disease (MRD) Testing total market by Type, CAGR, 2018-2029, (USD Million)

Global Minimal Residual Disease (MRD) Testing total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Minimal Residual Disease (MRD) Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sysmex Corporation, Natera, Asuragen, Quest Diagnostics, Mission Bio, LabCorp, Guardant Health, NeoGenomics Laboratories and ARUP Laboratories, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Minimal Residual Disease (MRD) Testing market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Minimal Residual Disease (MRD) Testing Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Minimal Residual Disease (MRD) Testing Market, Segmentation by Type
Flow Cytometry
Polymerase Chain Reaction
Next-generation Sequencing
Liquid Biopsies

Global Minimal Residual Disease (MRD) Testing Market, Segmentation by Application
Specialty Clinics
Hospitals
Research Institutions

Companies Profiled:
Sysmex Corporation
Natera
Asuragen
Quest Diagnostics
Mission Bio
LabCorp
Guardant Health
NeoGenomics Laboratories
ARUP Laboratories
NeoGenomics , Inc
Opko Health
Bio-Rad Laboratories

Key Questions Answered

1. How big is the global Minimal Residual Disease (MRD) Testing market?

2. What is the demand of the global Minimal Residual Disease (MRD) Testing market?

3. What is the year over year growth of the global Minimal Residual Disease (MRD) Testing market?

4. What is the total value of the global Minimal Residual Disease (MRD) Testing market?

5. Who are the major players in the global Minimal Residual Disease (MRD) Testing market?

6. What are the growth factors driving the market demand?